We are live on ! Find out more
PG

Pendal Group Portfolio holdings

AUM $11.6B
1-Year Est. Return 12.87%
This Fund
S&P 500
This Quarter Est. Return
+1.65%
1 Year Est. Return
-12.87%
3 Year Est. Return
+52.75%
5 Year Est. Return
+103.82%
10 Year Est. Return
AUM
$12.1B
AUM Growth
+$1.2B
Cap. Flow
+$1.49B
Cap. Flow %
12.26%
Top 10 Hldgs %
30.95%
Holding
675
New
129
Increased
199
Reduced
220
Closed
109

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$463M
2
BABA icon
Alibaba
BABA
+$168M
3
UNH icon
UnitedHealth
UNH
+$142M
4
LIN icon
Linde
LIN
+$136M
5
CHKP icon
Check Point Software Technologies
CHKP
+$129M

Top Sells

Rank Stock Value
1
PRAH
PRA Health Sciences, Inc.
PRAH
+$115M
2
MEDP icon
Medpace
MEDP
+$115M
3
ORCL icon
Oracle
ORCL
+$112M
4
MKSI icon
MKS Inc
MKSI
+$99.1M
5
ARMK icon
Aramark
ARMK
+$92.8M

Sector Composition

Rank Sector Weight
1 Technology 20.61%
2 Healthcare 16.66%
3 Financials 15.34%
4 Consumer Discretionary 9.67%
5 Communication Services 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUPH icon
551
Aurinia Pharmaceuticals
AUPH
$1.95B
$221K ﹤0.01%
+10,000
New +$159K
CLX icon
552
Clorox
CLX
$12B
$214K ﹤0.01%
1,292
-735
-36% -$127K
AES icon
553
AES
AES
$10.6B
$213K ﹤0.01%
9,347
-33,506
-78% -$814K
RDUS
554
DELISTED
Radius Recycling
RDUS
$213K ﹤0.01%
+4,851
New +$234K
PCG icon
555
PG&E
PCG
$39B
$212K ﹤0.01%
22,087
-2,985
-12% -$28.2K
WH icon
556
Wyndham Hotels & Resorts
WH
$5.61B
$210K ﹤0.01%
2,727
-368
-12% -$26.4K
CNC icon
557
Centene
CNC
$30.5B
$209K ﹤0.01%
+3,347
New +$224K
CPB icon
558
Campbell Soup
CPB
$6.85B
$209K ﹤0.01%
+4,992
New +$217K
EW icon
559
Edwards Lifesciences
EW
$49.4B
$203K ﹤0.01%
+1,791
New +$204K
LFST icon
560
Lifestance Health
LFST
$4.15B
$201K ﹤0.01%
13,830
+1,482
+12% +$28.5K
HBAN icon
561
Huntington Bancshares
HBAN
$34B
$194K ﹤0.01%
12,574
-14,610
-54% -$215K
TWNK
562
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$176K ﹤0.01%
10,150
-1,372
-12% -$22.2K
VRN
563
DELISTED
Veren
VRN
$173K ﹤0.01%
37,571
+1,164
+3% +$4.3K
DISCK
564
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$113K ﹤0.01%
4,663
-9,421
-67% -$252K
RDS.A
565
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$107K ﹤0.01%
+2,398
New +$96.7K
NSTC.U
566
DELISTED
Northern Star Investment Corp. III Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTC.U
$105K ﹤0.01%
10,679
+25
+0.2% +$248
ABT icon
567
Abbott
ABT
$187B
-4,825
Closed -$559K
AFL icon
568
Aflac
AFL
$65.5B
-35,353
Closed -$1.9M
AGCO icon
569
AGCO
AGCO
$8.41B
-2,268
Closed -$296K
AGI icon
570
Alamos Gold
AGI
$12B
-113,176
Closed -$864K
AMH icon
571
American Homes 4 Rent
AMH
$12.1B
-18,500
Closed -$719K
AMP icon
572
Ameriprise Financial
AMP
$47.8B
-3,062
Closed -$762K
ATR icon
573
AptarGroup
ATR
$8.69B
-2,464
Closed -$347K
AVT icon
574
Avnet
AVT
$6.86B
-8,398
Closed -$337K
AZEK
575
DELISTED
The AZEK Co
AZEK
-5,445
Closed -$231K

Similar funds

Pendal Group's Q3 2021 Portfolio in Review

As of Q3 2021, Pendal Group held 675 positions worth $12.1B, up 11% from $10.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pendal Group deployed $1.49B of net new capital in Q3 2021, opening 129 new positions and adding to 199 existing holdings. Its largest new stake was BioNTech: 1,455,825 shares worth $397M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Medpace, an estimated $115M trimmed.

  • Pendal Group's largest Q3 2021 buy was BioNTech: 1,455,825 shares worth $397M.
  • Pendal Group added most to Alibaba in Q3 2021, an estimated $168M increase.
  • Pendal Group's biggest Q3 2021 reduction was Medpace, cutting an estimated $115M.
  • Pendal Group fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $115M.
  • Pendal Group's ten largest holdings make up 31% of its $12.1B portfolio in Q3 2021.
  • Pendal Group opened 129 new positions and closed 109 in Q3 2021.
  • Pendal Group's portfolio value rose 11% quarter-over-quarter to $12.1B.

Based on Pendal Group's 13F filing for Q3 2021, filed 5 Nov 2021.